| 11253523 |
Tofacitinib oral sustained release dosage forms |
Sriram Krishnaswami, Joseph Kushner, IV, Manisha Lamba, Thomas C. Stock |
2022-02-22 |
| 10639309 |
Tofacitinib oral sustained release dosage forms |
Sriram Krishnaswami, Joseph Kushner, IV, Manisha Lamba, Thomas C. Stock |
2020-05-05 |
| 9937181 |
Tofacitinib oral sustained release dosage forms |
Sriram Krishnaswami, Joseph Kushner, IV, Manisha Lamba, Thomas C. Stock |
2018-04-10 |
| 8431159 |
Solid pharmaceutical dispersions with enhanced bioavailability |
William J. Curatolo, James A. S. Nightingale |
2013-04-30 |
| 8367118 |
Solid pharmaceutical dispersions with enhanced bioavailability |
William J. Curatolo, James A. S. Nightingale |
2013-02-05 |
| 8337899 |
Solid pharmaceutical dispersions with enhanced bioavailability |
William J. Curatolo, James A. S. Nightingale |
2012-12-25 |
| 8263128 |
Solid pharmaceutical dispersions with enhanced bioavailability |
William J. Curatolo, James A. S. Nightingale |
2012-09-11 |
| 8257741 |
Solid pharmaceutical dispersions with enhanced bioavailability |
William J. Curatolo, James A. S. Nightingale |
2012-09-04 |
| 7887844 |
Multiparticulate crystalline drug compositions having controlled release profiles |
Leah E. Appel, Roderick J. Ray, David Keith Lyon, James B. West, Scott B. McCray +3 more |
2011-02-15 |
| 7550158 |
Controlled release by extrusion of solid amorphous dispersions of drugs |
Leah E. Appel, William J. Curatolo, James A. S. Nightingale, Avinash Thombre |
2009-06-23 |
| 6984403 |
Azithromycin dosage forms with reduced side effects |
Timothy Hagen, Julian B. Lo, Avinash Thombre, Leah E. Appel, Marshall Crew +4 more |
2006-01-10 |
| 6706283 |
Controlled release by extrusion of solid amorphous dispersions of drugs |
Leah E. Appel, William J. Curatolo, James A. S. Nightingale, Avinash Thombre |
2004-03-16 |
| 6641840 |
Sustained release formulations for growth hormone secretagogues |
Mary Am Ende, William J. Curatolo |
2003-11-04 |
| 6517866 |
Sertraline salts and sustained-release dosage forms of sertraline |
Mary Am Ende, William J. Curatolo, Hylar L. Friedman, Dwayne T. Friesen, Ravi Mysore Shankar +1 more |
2003-02-11 |
| 5876752 |
Use of interfacially-polymerized membranes in delivery devices |
Richard W. Korsmeyer, Avinash Thombre |
1999-03-02 |
| 5827538 |
Osmotic devices having vapor-permeable coatings |
Edward L. Cussler, Kelly L. Smith, Paul van Eikeren |
1998-10-27 |
| 5798119 |
Osmotic-delivery devices having vapor-permeable coatings |
Eric Miller |
1998-08-25 |
| 5698220 |
Asymmetric membranes in delivery devices |
John R. Cardinal, Richard W. Korsmeyer, Jeelin Lo, Kelly L. Smith, Avinash Thombre |
1997-12-16 |
| 5612059 |
Use of asymmetric membranes in delivery devices |
John R. Cardinal, Richard W. Korsmeyer, Jeelin Lo, Kelly L. Smith, Avinash Thombre |
1997-03-18 |
| 5609590 |
PH-triggered osmotic bursting delivery devices |
Kelly L. Smith |
1997-03-11 |
| 5603953 |
Supported liquid membrane delivery devices |
Kelly L. Smith, Paul van Eikeren, James B. West |
1997-02-18 |
| 5358502 |
PH-triggered osmotic bursting delivery devices |
Kelly L. Smith |
1994-10-25 |
| 5091080 |
Adsorbents for the removal of volatile substances from aqueous systems |
Paul van Eikeren, Daniel J. Brose |
1992-02-25 |
